Concerns growing over downward trend of drug pricing

Published: 2011-06-02 07:00:00

Updated: 2011-06-02 07:00:00

With the government’s relentless price cuts of drugs, there is widespread consensus in local industry that Korean drug manufacturers will not afford to spend their money on the development of new drugs.

The health ministry’s new drug pricing policy and crackdown on rebates is ultimately design...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK